Search

Your search keyword '"Fiammenghi Laura"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Fiammenghi Laura" Remove constraint Author: "Fiammenghi Laura"
29 results on '"Fiammenghi Laura"'

Search Results

1. FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

2. Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

3. Evaluation of in vivo labelled dendritic cell migration in cancer patients

8. Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)

9. Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

10. A Dendritic Cell (DC) microRNA signature predicts clinical outcome in Melanoma Patients treated with DC vaccine

11. Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose interleukin-2: Interim analysis data.

14. Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study

15. Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients.

16. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

17. Dendritic cell-based vaccine in advanced melanoma

18. Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”

20. Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

21. Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome

26. Case Report of Different Responses to Dendritic Cell Vaccination in a Melanoma Patient: Complete Remission with Autologous Tumor Lysate, but No Response with Autologous Tumor Homogenate

27. Immunosuppression in Renal Cancer: Differential Expression of Signal Transduction Molecules in Tumor-Infiltrating, Near-Tumor Tissue, and Peripheral Blood Lymphocytes

28. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.

29. DC Vaccine Potency Correlates With Efficient Induction of Tumor-specific Immune Responses After Vaccination of Advanced Melanoma Patients: Preliminary Data With an in vitro Functional Assay

Catalog

Books, media, physical & digital resources